Is true Nordic unity in life science financing possible? That was the core question when venture investors from Finland, Sweden, Denmark, Iceland and Norway met on stage on the final day of BioStock Life Science Summit 2026. The Nordic countries have much in common, but when it comes to funding and building life science companies, each market has its own character.
Moderated by Kristofer Klerfalk, Managing Partner at the angel network Life Science Invest, the panel brought together Pekka Simula, Partner at Innovestor Life Science, Linda Spahiu Elvesjö, Principal at Sound Bioventures, Stephan Christgau, Founding Partner at Eir Ventures, Svana Gunnarsdóttir, Co-founder and Managing Partner at Frumtak Ventures, and Farzad Abdi-Dezfuli, Partner at Sarsia. Together they compared where each country stands out, what holds its companies back, and how the region could work together going forward.
The panel did more than discuss the question. It arrived at both an answer and a possible solution to the growth financing gap that Nordic life science has long struggled with.
See the full panel discussion “A Nordic united? How VCs View the Region’s Strengths and Hurdles” below to find out what it is.
